TP53 and neoplasm of testis: In fact, refractory/relapsed TGCTs and primary mediastinal GCTs have been reported to be characterized by frequent MDM2 amplification and TP53 mutations: the first being mostly found in testicular tumors, whereas TP53 mutations were primarily found in mediastinal GCTs [19,22,23,24].